ICD Implantation with and without Combined Myocardial Revascularisation - Incidence of ICD Therapy and Late Survival

Abstract

Background: Our aim was to evaluate the occurrence of implanted cardioverter-defibrillator (ICD) shock and antitachycardia pacing (ATP), the effect of ICD therapies on mortality and the impact of revascularisation strategies on arrhythmic events. Patients and Methods: We investigated 130 CAD patients undergoing ICD implantation between 1984 and 1999. Results: Freedom of shock was 66 ± 7 %, 48 ± 9 % and 48 ± 9 % after 1, 3 and 5 years in patients with revascularisation and 62 ± 8 %, 43 ± 8 % and 23 ± 11 % in patients without revascularisation, respectively; p = n. s. Freedom from ATP was similar in both groups - in patients with revascularisation, 64 ± 6 %, 58 ± 7 % and 58 ± 7 % and without revascularisation 56 ± 8 %, 51 ± 9 % and 38 ± 10 %, respectively; p = n. s. There were no significant differences in cumulative survival between patients with and without revascularisation; p = n. s. Conclusions: CAD patients with VT/VF and with implanted ICD have, despite successful revascularisation, the same rate of device therapy and mortality as patients without an indication of revascularisation. This implies that patients with chronic ischemic heart disease and ventricular tachyarrhythmias continue to be at risk of sudden death after CABG/PTCA; evaluation for ICD implantation is warranted.

Implantable cardioverter defibrillator sudden death - ventricular arrhythmias - cardiovascular disease - revascularisation

References

• 1 Geelen P, Filho L, Primo J, Wellens F, Brugada P. Experience with implantable cardioverter defibrillator therapy in elderly patients.  Eur Heart J. 1997;  18 1339-1342
• 2 Nisam S, Mower M, Moser S. ICD clinical update: first decade, initial 10 000 patients.  Pacing Clin Electrophysiol. 1991;  14 255-262
• 3 Lampert R, Rosenfeld L, Batsford W, Lee F, McPherson C. Circadian variation of sustained ventricular tachycardia in patients with coronary artery disease and implantable cardioverter defibrillator.  Circulation. 1994;  90 241-247
• 4 Duru F, Candinas R. Potential proarrhythmic effects of implantable cardioverter-defibrillator.  Clin Cardiol. 1999;  22 139-146
• 5 Jordaens L, Vertongen P, Provenier F, Trouerbach J W, Poelaert J, Herregods L. A new transvenous internal cardioverter-defibrillator: Implantation techniques, complications and short-term follow-up.  Am Heart J. 1995;  129 251-258
• 6 Markewitz A, Kaulbach H, Mattke S. et al . One-incision approach for insertion of implantable cardioverter defibrillators.  Ann Thorac Surg. 1994;  58 1609-1613
• 7 Stanton M S, Hayes D L, Munger T M. et al . Consistent subcutaneous prepectoral implantation of a new implantable cardioverter defibrillator.  Mayo Clin Proc. 1994;  69 309-314
• 8 Leitch J W, Gillis A M, Wyse D G. et al . Reduction in defibrillation shocks with an implantable device combining antitachycardia pacing and shock therapy?.  J Am Coll Cardiol. 1991;  18 145-151
• 9 Pirzada F A. Implantable cardioverter defibrillator (ICD) is becoming more accepted in the treatment of cardiac arrhythmias.  Pacing Clin Electrophysiol. 1997;  20 140-141
• 10 Quan K J, Lee J H, Costantini O. Favorable results of implantable cardioverter-defibrillator implantation in patients older than 70 years.  Ann Thorac Surg. 1997;  64 1713-1717
• 11 Uretsky B F, Sheahan R G. Primary prevention of sudden cardiac death in heart failure: will the solution be shocking?.  J Am Coll Cardiol. 1997;  30 1589-1597
• 12 Buxton A E, Lee K L, Fisher J D, Josephson M E, Prystowsky E N, Hafley G. A randomized study of the prevention of sudden death in patients with coronary artery disease.  New Engl J Med. 1999;  341 1882-1890
• 13 Ruppel R, Schluter C A, Boczor S. et al . Ventricular tachycardia during follow-up in patients resuscitated from ventricular fibrillation: experience from stored electrograms of implantable cardioverter-defibrillators.  J Am Coll Cardiol. 1998;  32 1724-1730
• 14 De Sutter J, Kazmierczak J, Fonteyne W, Tavernier R, Jordaens L J. Factors determining long-term outcomes and survival in patients with coronary artery disease and ventricular tachyarrhythmias.  Pacing Clinical Electrophysiol. 2000;  23 1947-1952
• 15 Weiss J N, Koonlawee N, Stevenson W G, Singh B. (UCLA Conference): Ventricular arrhythmias in ischemic heart disease.  Ann Intern Medicine. 1991;  114 784-797
• 16 Fogoros R N, Elson J J, Bonnet C A. Actuarial incidence and pattern of occurrence of shocks following implantation of the automatic implantable cardioverter defibrillator.  J Am Coll Cardiol. 1989;  14 508-512
• 17 Kaplan E L, Meier P. Nonparametric estimation from incomplete observations.  J Am Stat Assoc. 1958;  53 457-481
• 18 Cox D R. Regression models and life-tables.  J R Stat Soc [B]. 1972;  34 187-220
• 19 Autschbach R, Falk V, Gonska B D, Dalichau H. The effect of coronary bypass graft surgery for the prevention of sudden cardiac death: recurrent episodes after ICD implantation and review of literature.  Pacing Clinical Electrophysiology. 1994;  17 552-558
• 20 Spotnitz H M, Herre J M, Raza S T. et al . Effect of implantable cardioverter-defibrillator implantation on surgical morbidity in the CABG Patch Trial. Surgical Investigators of the Coronary Artery Bypass Graft Patch Trial.  Circulation. 1998;  98 (Suppl II) 77-80